Edwards Lifesciences (EW) PT Lowered to $76 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St set to open higher as oil slips; telecoms hit by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $84.24 --0%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 33
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 33
Join SI Premium – FREE
Truist Securities analyst Richard Newitter lowered the price target on Edwards Lifesciences (NYSE: EW) to $76.00 (from $83.00) while maintaining a Buy rating.
You May Also Be Interested In
- UBS Reiterates Buy Rating on Edwards Lifesciences (EW)
- Barclays Starts Edwards Lifesciences (EW) at Overweight
- Crocs (CROX) PT Lowered to $145 at Williams Trading
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
